Seroatlas · Human Serome Atlas

CD14

Monocyte differentiation antigen CD14

Also known as: CD14_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P08571
Gene
CD14
Ensembl
ENSG00000170458
Chromosome
5
Canonical length
375 aa
Protein class
Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters
Subcellular location
Vesicles
Secretome location
Secreted to blood

OverviewNCBI Gene

The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. It cooperates with other proteins to mediate the innate immune response to bacterial lipopolysaccharide, and to viruses. This gene has been identified as a target candidate in the treatment of SARS-CoV-2-infected patients to potentially lessen or inhibit a severe inflammatory response. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Aug 2020]

Canonical amino-acid sequenceUniProt

375 residues, UniProt reviewed canonical sequence.

>P08571|CD14
     1  MERASCLLLL LLPLVHVSAT TPEPCELDDE DFRCVCNFSE PQPDWSEAFQ CVSAVEVEIH
    61  AGGLNLEPFL KRVDADADPR QYADTVKALR VRRLTVGAAQ VPAQLLVGAL RVLAYSRLKE
   121  LTLEDLKITG TMPPLPLEAT GLALSSLRLR NVSWATGRSW LAELQQWLKP GLKVLSIAQA
   181  HSPAFSCEQV RAFPALTSLD LSDNPGLGER GLMAALCPHK FPAIQNLALR NTGMETPTGV
   241  CAALAAAGVQ PHSLDLSHNS LRATVNPSAP RCMWSSALNS LNLSFAGLEQ VPKGLPAKLR
   301  VLDLSCNRLN RAPQPDELPE VDNLTLDGNP FLVPGTALPH EGSMNSGVVP ACARSTLSVG
   361  VSGTLVLLQG ARGFA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CD14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.34
Highest tissue expression
426 nTPM

Expression across tissuesHPA

Tissue

  • liver: 426 nTPM
  • adrenal gland: 180 nTPM
  • appendix: 177 nTPM
  • placenta: 143 nTPM
  • salivary gland: 134 nTPM
  • adipose tissue: 122 nTPM

Single-cell type

  • hofbauer cells: 6,154 nCPM
  • breast lactating cells: 1,507 nCPM
  • monocytes: 675 nCPM
  • macrophages: 626 nCPM
  • hepatocytes: 437 nCPM
  • neutrophils: 419 nCPM

Immune cell

  • classical monocyte: 3,501 nTPM
  • total PBMC: 2,909 nTPM
  • neutrophil: 935 nTPM
  • intermediate monocyte: 632 nTPM
  • myeloid DC: 397 nTPM
  • non-classical monocyte: 90 nTPM

Brain region

  • white matter: 73 nTPM
  • medulla oblongata: 56 nTPM
  • thalamus: 51 nTPM
  • pons: 49 nTPM
  • choroid plexus: 41 nTPM
  • spinal cord: 41 nTPM

ReferencesPubMed · IEDB

Publications for CD14 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.59
gnomAD pLI
0
gnomAD missense Z
0.55
DepMap mean gene effect
-0.06
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CD14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CD14 as an antibody target. Whether an autoantibody or antibody against CD14 could matter depends on whether native CD14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CD14 is annotated at the cell surface, where native CD14 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CD14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CD14. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...